InMode Ltd (NAS:INMD)
$ 17.41 -0.95 (-5.17%) Market Cap: 1.47 Bil Enterprise Value: 708.89 Mil PE Ratio: 8.25 PB Ratio: 1.81 GF Score: 87/100

Inmode Ltd at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 05:35PM GMT
Release Date Price: $12.2 (-11.53%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Thank you, and good afternoon. This is Jack Meehan from the Barclays Tools and Diagnostics team. Appreciate you joining us on the new virtual format for the conference.

Next, our next presentation is with InMode, in the medical aesthetics space. We're joined by Co-Founder and CEO, Moshe Mizrahy; also have on the line, CFO, Yair Malca. And I'm going to turn it over to Moshe. He's going to give some thoughts. And I think at the end, we're going to do a little Q&A. Thanks.

Moshe Mizrahy
InMode Ltd. - Chairman & CEO

Okay. Thank you, Jack. With me today, Yair Malca, our CFO, if you have any question regarding financial or anything else; but also Miri Segal, our external IR lady. She's based in New York. Yair is based in California.

I hope that this -- my presentation will be clear, although it's more difficult when I don't see you and you don't see me, but we will try to do the best. For those of you who want to see my presentation in full, we uploaded

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot